Versor Investments LP boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 170.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 41,100 shares of the company’s stock after purchasing an additional 25,900 shares during the quarter. Versor Investments LP’s holdings in Bath & Body Works were worth $1,059,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of BBWI. First Horizon Corp purchased a new position in Bath & Body Works in the 3rd quarter worth approximately $29,000. Geneos Wealth Management Inc. grew its holdings in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the period. Carolina Wealth Advisors LLC purchased a new stake in Bath & Body Works in the 3rd quarter worth approximately $54,000. Parkside Financial Bank & Trust lifted its stake in shares of Bath & Body Works by 24.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after buying an additional 364 shares in the last quarter. Finally, Westfuller Advisors LLC purchased a new stake in shares of Bath & Body Works during the third quarter worth about $56,000. 95.14% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on BBWI. Jefferies Financial Group initiated coverage on Bath & Body Works in a report on Wednesday, January 14th. They set a “hold” rating and a $24.00 price objective on the stock. Zacks Research upgraded Bath & Body Works from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 20th. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Telsey Advisory Group lowered shares of Bath & Body Works from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $38.00 to $17.00 in a research note on Friday, November 21st. Finally, Morgan Stanley reaffirmed an “equal weight” rating and set a $18.00 target price (down previously from $43.00) on shares of Bath & Body Works in a research report on Friday, November 21st. Five equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $23.53.
Insider Transactions at Bath & Body Works
In other news, Director Steven E. Voskuil purchased 20,000 shares of the firm’s stock in a transaction on Friday, November 21st. The shares were bought at an average cost of $15.04 per share, for a total transaction of $300,800.00. Following the completion of the purchase, the director directly owned 33,925 shares of the company’s stock, valued at approximately $510,232. This trade represents a 143.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Francis Hondal acquired 3,343 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was purchased at an average cost of $14.99 per share, with a total value of $50,111.57. Following the completion of the purchase, the director directly owned 21,554 shares of the company’s stock, valued at approximately $323,094.46. This represents a 18.36% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 33,513 shares of company stock worth $500,442 in the last ninety days. 0.27% of the stock is owned by company insiders.
Bath & Body Works Stock Up 0.3%
BBWI stock opened at $23.12 on Tuesday. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $41.87. The stock has a market capitalization of $4.73 billion, a P/E ratio of 7.11, a P/E/G ratio of 1.02 and a beta of 1.54. The firm has a 50-day simple moving average of $21.02 and a 200-day simple moving average of $24.27.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the firm posted $0.49 earnings per share. The business’s revenue was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. On average, analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, March 6th. Shareholders of record on Friday, February 20th will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend is Friday, February 20th. Bath & Body Works’s dividend payout ratio (DPR) is 24.62%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Articles
- Five stocks we like better than Bath & Body Works
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
